Search

The Use of Structural Biology in Janus Kinase Targeted Drug Discovery

Journal: Current Drug Targets
Volume: 12 Issue: 4 Year: 2011 Page: 546-555
Author(s): Nilda L. Alicea-Velazquez, Titus J. Boggon

Clinical Experience with Antiangiogenic Therapy in Leukemia

Journal: Current Cancer Drug Targets
Volume: 11 Issue: 9 Year: 2011 Page: 1053-1068
Author(s): J. Wellbrock, W. Fiedler

Immunotherapy for Myeloproliferative Neoplasms (MPN)

Journal: Current Cancer Drug Targets
Volume: 11 Issue: 1 Year: 2011 Page: 72-84
Author(s): Susanne Hofmann, Anna Babiak, Jochen Greiner

A Structure-Function Perspective of Jak2 Mutations and Implications for Alternate Drug Design Strategies: The Road not Taken

Journal: Current Medicinal Chemistry
Volume: 18 Issue: 3 Year: 2011 Page: 4659-4673
Author(s): K. Gnanasambandan, P.P. Sayeski

Current Treatment Concepts of Philadelphia-Negative MPN

Journal: Current Cancer Drug Targets
Volume: 11 Issue: 1 Year: 2011 Page: 44-55
Author(s): D. Wolf, J. Rudzki, G. Gastl

The Role of STAT 3 in Tissue Fibrosis

Journal: Current Chemical Biology
Volume: 5 Issue: 1 Year: 2011 Page: 44-51
Author(s): Li Ma, Shougang Zhuang

Molecular Pathogenesis of Philadelphia Chromosome Negative Chronic Myeloproliferative Neoplasms

Journal: Current Cancer Drug Targets
Volume: 11 Issue: 1 Year: 2011 Page: 20-30
Author(s): R. Jager, R. Kralovics

Journal: Current Cancer Drug Targets
Volume: 11 Issue: 1 Year: 2011 Page: 1-2
Author(s): Dominik Wolf, H. Rumpold

Interferon-Alpha in the Treatment of Philadelphia-Negative Chronic Myeloproliferative Neoplasms. Status and Perspectives

Journal: Current Drug Targets
Volume: 12 Issue: 3 Year: 2011 Page: 392-419
Author(s): Hans Carl Hasselbalch, Thomas Stauffer Larsen, Caroline Hasselbalch Riley, Morten Krogh Jensen, Jean-Jacques Kiladjian

Antiangiogenesis in Myelodysplastic Syndrome

Journal: Current Cancer Drug Targets
Volume: 11 Issue: 9 Year: 2011 Page: 1044-1052
Author(s): A. Aguayo, F. M. Armillas-Canseco, D. Martinez-Banos